J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Camejo, G.
Right arrow Articles by Bondjers, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camejo, G.
Right arrow Articles by Bondjers, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 32, 1983-1991, Copyright © 1991 by Lipid Research, Inc.


ARTICLES

Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans

G Camejo, E Hurt-Camejo, B Rosengren, O Wiklund, F Lopez and G Bondjers
Wallenberg Laboratory for Cardiovascular Research, University of Gothenburg, Sweden.

Chondroitin sulfate proteoglycans (CSPG) appear to contribute to retention of low density lipoproteins (LDL) in atherosclerotic lesions. In vitro, CSPG and glycosaminoglycans (GAG) modify LDL structure and increase its uptake by macrophages. This latter effect appears related to increased exposure of arginine- and lysine-rich segments of apoB- 100. We explored whether alterations of LDL induced by human arterial CSPG and purified GAG alter the lipoprotein susceptibility to transition metals-catalyzed oxidation. Human LDL was complexed with human arterial CSPG and dissociated by raising the ionic strength. The nonaggregated, CSPG- and GAG-treated LDL was subjected to oxidation by micromolar amounts of Cu+, Cu2+, Fe2+, and Fe3+. This treatment increased LDL susceptibility to Cu2+ oxidation 3- to 5-times, as indicated by the degradation rate of phospholipids and cholesteryl esters and formation rates of dienes and thiobarbituric acid-reacting substances (TBARS). Also, human macrophages degraded the CSPG-treated, Cu2+-oxidized LDL 3- to 6-times faster than native LDL similarly treated. No enhancement of oxidation was observed with Fe2+, Fe3+, and Cu+. Quenching of the LDL intrinsic fluorescence by Cu2+ showed that heparin, CSPG, and chondroitin-6-SO4 pretreatment increased the access of Cu2+ to hydrophobic chromophores, probably tryptophan, 6- to 7-, 3- to 4-, and 2- to 3-fold, respectively. Also, the affinity constant (Ka) of LDL for Cu2+ was increased from 0.12 microM to 0.20 microM by the treatment with CSPG and GAG. These results and evaluation of the fraction of surface-accessible LDL chromophores to acrylamide quenching suggest that the increased susceptibility to oxidation may be associated with an increase in the access of Cu2+ to hydrophobic regions in LDL caused by treatment with CSPG and GAG. This effect was not detected with Cu+, Fe2+, or Fe3+. The phenomenon may contribute to acceleration of the oxidative modifications of LDL in cell culture models and in vivo.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. F. Khalil, W. D. Wagner, and I. J. Goldberg
Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2211 - 2218.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Llorente-Cortes, M. Otero-Vinas, E. Hurt-Camejo, J. Martinez-Gonzalez, and L. Badimon
Human Coronary Smooth Muscle Cells Internalize Versican-Modified LDL Through LDL Receptor-Related Protein and LDL Receptors
Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 387 - 393.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. O. Pentikainen, K. Oorni, and P. T. Kovanen
Myeloperoxidase and Hypochlorite, but Not Copper Ions, Oxidize Heparin-Bound LDL Particles and Release Them From Heparin
Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1902 - 1908.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Kaplan and M. Aviram
Retention of Oxidized LDL by Extracellular Matrix Proteoglycans Leads to Its Uptake by Macrophages : An Alternative Approach to Study Lipoproteins Cellular Uptake
Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 386 - 393.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. M. UPSTON, A. C. TERENTIS, and R. STOCKER
Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement
FASEB J, June 1, 1999; 13(9): 977 - 994.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
N. F. Galeano, M. Al-Haideri, F. Keyserman, S. C. Rumsey, and R. J. Deckelbaum
Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity
J. Lipid Res., June 1, 1998; 39(6): 1263 - 1273.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Llorente-Cortes, J. Martinez-Gonzalez, and L. Badimon
Esterified Cholesterol Accumulation Induced by Aggregated LDL Uptake in Human Vascular Smooth Muscle Cells Is Reduced by HMG-CoA Reductase Inhibitors
Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 738 - 746.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Camejo, C. Halberg, A. Manschik-Lundin, E. Hurt-Camejo, B. Rosengren, H. Olsson, G. I. Hansson, G.-B. Forsberg, and B. Ylhen
Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages
J. Lipid Res., April 1, 1998; 39(4): 755 - 766.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Jovinge, M. Crisby, J. Thyberg, and J. Nilsson
DNA Fragmentation and Ultrastructural Changes of Degenerating Cells in Atherosclerotic Lesions and Smooth Muscle Cells Exposed to Oxidized LDL in Vitro
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2225 - 2231.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Oorni, M. O. Pentikainen, A. Annila, and P. T. Kovanen
Oxidation of Low Density Lipoprotein Particles Decreases Their Ability to Bind to Human Aortic Proteoglycans. DEPENDENCE ON OXIDATIVE MODIFICATION OF THE LYSINE RESIDUES
J. Biol. Chem., August 22, 1997; 272(34): 21303 - 21311.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Hurt-Camejo, U. Olsson, O. Wiklund, G. Bondjers, and G. Camejo
Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans: Potential Contribution to Atherogenesis
Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1011 - 1017.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. C. Stary, A. B. Chandler, R. E. Dinsmore, V. Fuster, S. Glagov, W. Insull Jr, M. E. Rosenfeld, C. J. Schwartz, W. D. Wagner, and R. W. Wissler
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1512 - 1531.
[Abstract] [Full Text]


Home page
CirculationHome page
H. C. Stary, A. B. Chandler, R. E. Dinsmore, V. Fuster, S. Glagov, W. Insull Jr, M. E. Rosenfeld, C. J. Schwartz, W. D. Wagner, and R. W. Wissler
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
Circulation, September 1, 1995; 92(5): 1355 - 1374.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Olsson, O. Wiklund, and G. Bondjers
Effects of Injury on ApoB Kinetics and Concentration in Rabbit Aorta
Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 930 - 936.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.